Newsroom
Sorted by: Latest
-
AM Best Assigns Issue Credit Rating to Intact Financial Corporation’s Senior Unsecured Medium-Term Notes and Subordinated Notes
OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has assigned a Long-Term Issue Credit Rating (Long-Term IR) of “a-” (Excellent) to the recently announced CAD 250 million, 3.784% senior unsecured medium-term notes, due February 2038, issued by Intact Financial Corporation (Intact) (Toronto, Ontario, Canada). At the same time, AM Best also has assigned a Long-Term IR of “bbb” (Good) to the recently announced CAD 250 million, 5.642% subordinated notes, due March 2086, also issued by Intact. The outlook as...
-
Sai Life Sciences va recruter plus de 700 professionnels au cours de l’exercice 2027
HYDERABAD, Inde--(BUSINESS WIRE)--Sai Life Sciences Limited (BSE : 544306 | NSE : SAILIFE), l’une des principales organisations intégrées de recherche, développement et fabrication sous contrat (CRDMO) en Inde, a annoncé aujourd’hui son intention de recruter plus de 700 professionnels scientifiques, techniques et de gestion au cours de la période 2026-2027, afin d’étendre ses capacités pour répondre à la demande mondiale croissante en matière de services complets de découverte, de développement...
-
A Project B az iparág veteránját, William Kimet nevezi ki lifestyle-igazgatónak
SZINGAPÚR--(BUSINESS WIRE)--A Project B, az új sportolói és rajongói generáció számára létrehozott, elit nemzetközi női és férfi kosárlabda-nagydíj-sorozat ma bejelentette, hogy William Kimet nevezi ki lifestyle-igazgatónak. Stratégiai szerepkörében Kim irányítja majd a Project B prémium lifestyle üzletágát – beleértve a merchandise-termékeket, a márkaegyüttműködéseket és a kulturális partnerségeket – miközben a Project B Európában, Ázsiában és az amerikai kontinensen terjeszkedik annak érdekéb...
-
Samenvatting: Sai Life Sciences werft meer dan 700 professionals aan in boekjaar 2027
HYDERABAD, India--(BUSINESS WIRE)--Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), een van India’s toonaangevende geïntegreerde CRDMO's (Contract Research, Development & Manufacturing Organizations), maakte vandaag plannen bekend om tijdens 2026-27 meer dan 700 wetenschappelijke, technische en beheerprofessionals aan te werven nu het bedrijf haar capaciteiten op schaal brengt om te beantwoorden aan de wereldwijd stijgende vraag naar end-to-end services voor het ontdekken, het ontwik...
-
Oberon Investments Plc UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Oberon Investments Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be nam...
-
ISG to Assess Palantir Ecosystem Partners
STAMFORD, Conn.--(BUSINESS WIRE)--ISG has launched a study of providers in the Palantir ecosystem and their consulting, implementation, operations and AI-driven analytics capabilities....
-
Acadia Healthcare to Participate in March Investor Conferences
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in three investor conferences in March. On Monday, March 2, 2026, the Company will participate in the Raymond James & Associates’ 47th Annual Institutional Investors Conference, being held March 1-4, 2026, in Orlando, Florida. The Company’s presentation/fireside chat will begin at 11:35 a.m. Eastern Time/10:35 a.m. Central Time. On Monday, March 9, 2026, the Com...
-
Dr. Reddy’s Announces USFDA Acceptance to Review Its Biologics License Application (BLA) for Proposed Interchangeable Biosimilar, Abatacept
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s announces USFDA acceptance to review its Biologics License Application (BLA) for proposed interchangeable biosimilar, Abatacept....
-
Sunbit Earns Spot on the 2026 Forbes Fintech 50, Cementing Its Leadership
LOS ANGELES--(BUSINESS WIRE)--Sunbit today announced its inclusion on the 2026 Forbes Fintech 50 list for the third consecutive year....
-
Balmain Beauty presenta Destin de Balmain: una nueva fragancia de prestigio
PARÍS--(BUSINESS WIRE)--Balmain Beauty presenta Destin de Balmain, su primera fragancia de prestigio. La nueva fragancia femenina es un “eau de parfum” atrevido, floral y afrutado que captura la energía arrolladora de la mujer Balmain: independiente, joven y sin complejos. LA HISTORIA: VIVE TU DESTINO Destin de Balmain es el destino que está en tus manos, un viaje de optimismo y posibilidades infinitas. La fragancia, en presentación recargable, une a quienes se expresan sin reglas ni expectativ...